HK1003111A1 - Benzomorphanes and their use as pharmaceuticals - Google Patents

Benzomorphanes and their use as pharmaceuticals Download PDF

Info

Publication number
HK1003111A1
HK1003111A1 HK98102148A HK98102148A HK1003111A1 HK 1003111 A1 HK1003111 A1 HK 1003111A1 HK 98102148 A HK98102148 A HK 98102148A HK 98102148 A HK98102148 A HK 98102148A HK 1003111 A1 HK1003111 A1 HK 1003111A1
Authority
HK
Hong Kong
Prior art keywords
denotes
group
alkyl
methyl
hydroxy
Prior art date
Application number
HK98102148A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1003111B (en
Inventor
Carter Adrian
Grauert Matthias
Merz Herbert
Stransky Werner
Ensinger Helmut
Josef Kuhn Franz
Muller Enzio
Streller Ilse
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of HK1003111B publication Critical patent/HK1003111B/xx
Publication of HK1003111A1 publication Critical patent/HK1003111A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/26—Benzomorphans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
HK98102148A 1991-07-02 1998-03-16 Benzomorphanes and their use as pharmaceuticals HK1003111A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4121821 1991-07-02
DE4121821A DE4121821A1 (de) 1991-07-02 1991-07-02 Neue benzomorphane und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
HK1003111B HK1003111B (en) 1998-10-09
HK1003111A1 true HK1003111A1 (en) 1998-10-09

Family

ID=6435223

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98102148A HK1003111A1 (en) 1991-07-02 1998-03-16 Benzomorphanes and their use as pharmaceuticals

Country Status (24)

Country Link
EP (1) EP0521422B1 (cs)
JP (1) JP3324785B2 (cs)
KR (1) KR100251256B1 (cs)
AT (1) ATE137749T1 (cs)
AU (1) AU657330B2 (cs)
CA (1) CA2072814C (cs)
CZ (1) CZ286949B6 (cs)
DE (2) DE4121821A1 (cs)
DK (1) DK0521422T3 (cs)
ES (1) ES2086585T3 (cs)
FI (1) FI105913B (cs)
GR (1) GR3020124T3 (cs)
HK (1) HK1003111A1 (cs)
HU (1) HU220873B1 (cs)
IE (1) IE74400B1 (cs)
IL (1) IL102361A (cs)
MX (1) MX9203845A (cs)
NO (1) NO178263C (cs)
NZ (1) NZ243388A (cs)
PH (1) PH31430A (cs)
SG (1) SG43001A1 (cs)
SK (1) SK280776B6 (cs)
TW (1) TW214547B (cs)
ZA (1) ZA924883B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528472A1 (de) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg Neues Verfahren zur Herstellung von Norbenzomorphan einer Zwischenstufe bei Herstellung von pharmazeutisch wertvollen Benzomorphanderivaten, insbesondere von (-)-(1R,5S,S"R)-3'-Hydroxy-2-(2-methoxypropyl-)-5,9,9-trimethyl-6,7 benzomorphan
DE19740110A1 (de) * 1997-09-12 1999-03-18 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocin-10-ole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
JPH1196519A (ja) * 1997-09-17 1999-04-09 Alps Electric Co Ltd スピンバルブ型薄膜素子およびその製造方法
US6136980A (en) * 1998-05-01 2000-10-24 Boehringer Ingelheim Kg Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane
DE19826365A1 (de) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Verwendung von Benzomorphanderivaten als Analgetikum
DE19957156A1 (de) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma Substituierte 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE10204276A1 (de) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocine und ihre Verwendung als Arzneimittel
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP1506174B1 (en) 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
AR069545A1 (es) * 2007-11-16 2010-02-03 Boehringer Ingelheim Pharma Derivados de aril y heteroarilcarbonilo de benzomorfanos y estructuras relacionadas, composiciones farmaceuticas que contienen dichos compuestos, obtencion de las mismas, su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa (hsd) 1 y
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7804509A (nl) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan.
DE2828039A1 (de) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung
NL7907800A (nl) * 1979-10-23 1981-04-27 Acf Chemiefarma Nv Nieuwe 6,7-benzomorfanderivaten en zuuradditiezouten daarvan, farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen en de farmaceutische preparaten.

Also Published As

Publication number Publication date
EP0521422B1 (de) 1996-05-08
DE4121821A1 (de) 1993-01-14
CZ207592A3 (en) 1993-08-11
CA2072814C (en) 2003-09-23
CZ286949B6 (cs) 2000-08-16
IE922144A1 (en) 1993-01-13
SK280776B6 (sk) 2000-07-11
KR930002321A (ko) 1993-02-22
MX9203845A (es) 1993-01-01
IE74400B1 (en) 1997-07-30
IL102361A0 (en) 1993-01-14
ZA924883B (en) 1993-02-24
EP0521422A1 (de) 1993-01-07
FI923050L (fi) 1993-01-03
PH31430A (en) 1998-11-03
AU657330B2 (en) 1995-03-09
HU220873B1 (en) 2002-06-29
CA2072814A1 (en) 1993-01-03
HU9202199D0 (en) 1992-10-28
DK0521422T3 (da) 1996-06-10
NO178263B (no) 1995-11-13
NO178263C (no) 1996-02-21
FI105913B (fi) 2000-10-31
KR100251256B1 (ko) 2000-05-01
TW214547B (cs) 1993-10-11
GR3020124T3 (en) 1996-08-31
ES2086585T3 (es) 1996-07-01
SG43001A1 (en) 1997-10-17
FI923050A0 (fi) 1992-07-01
JP3324785B2 (ja) 2002-09-17
NO922603D0 (no) 1992-07-01
ATE137749T1 (de) 1996-05-15
JPH05201987A (ja) 1993-08-10
NO922603L (no) 1993-01-04
SK207592A3 (en) 1997-01-08
DE59206212D1 (de) 1996-06-13
NZ243388A (en) 1994-11-25
IL102361A (en) 1997-02-18
HUT66410A (en) 1994-11-28
AU1868692A (en) 1993-01-07

Similar Documents

Publication Publication Date Title
DE3527648C2 (cs)
US5731318A (en) Benzomorphan derivatives
US4451470A (en) Analgesic, antagonist, and/or anorectic 14-fluoromorphinans
HK1003111A1 (en) Benzomorphanes and their use as pharmaceuticals
HK1003111B (en) Benzomorphanes and their use as pharmaceuticals
OA10200A (fr) Nouveaux dérivés de l'érythromycine leur procédé de préparation et leur application comme médicaments
JP2001527058A (ja) ノイラミニダーゼ阻害剤として有用な置換シクロペンタン及びシクロペンテン化合物
JPS60358B2 (ja) ベンゾモルフアン化合物の製法
US4374139A (en) Levorotatory N-substituted acylmorphinans useful as analgesic agents
US4320148A (en) 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
JPH0559049A (ja) Ｎ−（アリールオキシアルキル）ヘテロアリール−８−アザビシクロ〔３．２．１〕オクタン、中間体およびそれらの製法
US4087532A (en) Analgesically useful 2-tetrahydrofurfuryl-5-lower alkyl-2-oxy-6,7-benzomorphans and salts thereof
US4528289A (en) Corynantheine derivates, processes for their preparation, and their use
JPH02104587A (ja) Ｎ‐〔Ｎ‐（テトラヒドロピリド〔２，３‐ｄ〕ピリミジニルメチル）アミノメチルベンゾイル〕グルタミン酸誘導体
JPH0570457A (ja) 置換イミダゾール−２−オンの誘導体及びその製造方法
JP2002534530A (ja) 細胞癒着阻害剤としての単糖の２，３−ｏ−イソプロピリデン誘導体
EP0604352A2 (en) Aryl substituted heterocyclic compounds
PL80112B1 (cs)
IE55232B1 (en) "n-(2-methoxyethyl)-noroxymorphone"
EP0003286B1 (de) Ergopeptidalkaloid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0001585B1 (de) Piperazino-pyrrolobenzodiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Präparate enthaltend diese Verbindungen
KR830001838B1 (ko) 페닐-퀴놀리지딘의 제조방법
US4133888A (en) Analgesic and morphine antagonistic 2'-hydroxy-2-(5-isoxazolyl-methyl)-6,7-benzomorphans and salts thereof
US20050043396A1 (en) 5-Benzoylamino-1,3-dioxacyclanes, the method for preparing the same and their use as PKC inhibitor
EP0147774B1 (en) 4,7-dimethyl-2-(4-pyridinyl)-1,2,4-triazolo(1,5-a)pyrimidine-5(4h)-one

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20120626